Vaccines

10 Dec 2009 Merck KGaA Starts Stimuvax Phase III Study INSPIRE in Asian Patients with Advanced NSCLC
09 Dec 2009 Sanofi Pasteur Global Dengue Vaccine Clinical Program Expanded in Latin America
09 Dec 2009 Nabi Biopharmaceuticals to Receive $5 Million Milestone Payment From GlaxoSmithKline Biologicals
09 Dec 2009 Immunovaccine Receives Clearance From FDA to Proceed With Phase 1 Clinical Trial for Its Therapeutic Cancer Vaccine
08 Dec 2009 Neovacs Initiates a Phase II Clinical Trial of TNF Kinoid in Rheumatoid Arthritis Patients Failing TNF Monoclonal Antibody Therapy
07 Dec 2009 Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study
02 Dec 2009 NOVAVAX Reports Positive Clinical Results from Pivotal Study of H1N1 Influenza Vaccine in Mexico
01 Dec 2009 GSK Update: GSK’s Arepanrix™ H1N1 pandemic vaccine prequalified by the World Health Organization
30 Nov 2009 NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults
27 Nov 2009 STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe
27 Nov 2009 The ChronVac-C study has been successfully completed with good safety and favorable clinical data
27 Nov 2009 FDA Approves Agriflu Seasonal Influenza Vaccine
26 Nov 2009 Planet Biopharmaceuticals Announces Annual Meeting and Results of Clinical Trials
23 Nov 2009 Vical Completes Final Patient Follow-Up in TransVax(TM) CMV Vaccine Phase 2 Trial
20 Nov 2009 Inovio Biomedical Universal Flu Vaccines Demonstrate Broadly Protective Immune Responses Against Multiple Seasonal & Pandemic Influenza Viruses in Pre-Clinical Studies
20 Nov 2009 Circassia Announces Successful Results From Phase II Clinical Study of ToleroMune(R) Cat Allergy Therapy
20 Nov 2009 European CHMP Formally Adopts Negative Opinion on Oncophage
19 Nov 2009 Dynavax Completes Enrollment of First Cohort of Patients in Phase 1b Clinical Trial for Hepatitis B Therapy
19 Nov 2009 FDA Advisory Committee Finds Data Support the Safety and Effectiveness of Prevnar 13™ Vaccine for the Prevention of Invasive Pneumococcal Disease in Infants and Young Children
18 Nov 2009 Alzheimer's Vaccine on the Right Track
18 Nov 2009 Inovio Biomedical Universal DNA Vaccine for Chikungunya Virus Demonstrates Protective Antibody Responses in Monkey Model
17 Nov 2009 Novartis Influenza A(H1N1) 2009 vaccine US interim data show lower doses of antigen may suffice to generate a protective immune response against A(H1N1)
16 Nov 2009 GSK and Nabi Announce Agreement for NicVAX(R), a Vaccine for Nicotine Addiction
16 Nov 2009 Panenza®*, Sanofi Pasteur’s Influenza A(H1N1) 2009 Vaccine, Approved in France
13 Nov 2009 Adeona Announces Publication of Results of 160 Patient Phase 2 Clinical Trial of Oral dnaJP1 for Rheumatoid Arthritis

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2020 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top